Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 731296, 7 pages
http://dx.doi.org/10.1155/2014/731296
Clinical Study

Resistance to Erythropoiesis-Stimulating Agents Is Associated with Arterial Microcalcification in Early Hemodialysis Patients

1Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
3Division of Nephrology, Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 271 Cheon bo-ro, Uijeongbu-si, Gyeonggi-do 480-717, Republic of Korea

Received 3 December 2013; Accepted 16 February 2014; Published 17 March 2014

Academic Editor: Koji Ikeda

Copyright © 2014 Hye Sung Won et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. H. Horl, “Anaemia management and mortality risk in chronic kidney disease,” Nature Reviews Nephrology, vol. 9, no. 5, pp. 291–301, 2013. View at Google Scholar
  2. G. M. London, A. P. Guérin, S. J. Marchais, F. Métivier, B. Pannier, and H. Adda, “Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality,” Nephrology Dialysis Transplantation, vol. 18, no. 9, pp. 1731–1740, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Panichi, A. Rosati, R. Bigazzi et al., “Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study,” Nephrology Dialysis Transplantation, vol. 26, no. 8, pp. 2641–2648, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. W. Johnson, C. A. Pollock, and I. C. Macdougall, “Erythropoiesis-stimulating agent hyporesponsiveness,” Nephrology, vol. 12, no. 4, pp. 321–330, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Jofré, P. Rodriguez-Benitez, J. M. López-Gómez, and R. Pérez-Garcia, “Inflammatory syndrome in patients on hemodialysis,” Journal of the American Society of Nephrology, vol. 17, supplement 3, no. 12, pp. S274–S280, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. W. Kang, C. Y. Ahn, B. K. Ryu, B. C. Shin, J. H. Chung, and H. L. Kim, “The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia,” Kidney Research and Clinical Practice, vol. 31, no. 1, pp. 48–53, 2012. View at Google Scholar
  7. H. S. Won, H. G. Kim, Y. S. Yun et al., “IL-6 is an independent risk factor for resistance to erythropoiesis-stimulating agents in hemodialysis patients without iron deficiency,” Hemodialysis International, vol. 16, no. 1, pp. 31–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. N. X. Chen and S. M. Moe, “Vascular calcification: pathophysiology and risk factors,” Current Hypertension Reports, vol. 14, no. 3, pp. 228–237, 2012. View at Google Scholar
  9. J. B. Cannata-Andía, M. Rodríguez-García, N. Carrillo-López, M. Naves-Díaz, and B. Díaz-López, “Vascular calcifications: pathogenesis, management, and impact on clinical outcomes,” Journal of the American Society of Nephrology, vol. 17, supplement 3, no. 12, pp. S267–S273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-S. Shao, S.-L. Cheng, J. Sadhu, and D. A. Towler, “Inflammation and the osteogenic regulation of vascular calcification: a review and perspective,” Hypertension, vol. 55, no. 3, pp. 579–592, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. H. B. Chang, A. Javed, Q. Dai et al., “Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling,” Journal of Biological Chemistry, vol. 283, no. 22, pp. 15319–15327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. H. G. Kim, S. C. Park, S. L. Lee et al., “Arterial micro-calcification of vascular access is associated with aortic arch calcification and arterial stiffness in hemodialysis patients,” Seminars in Dialysis, vol. 26, no. 2, pp. 216–222, 2013. View at Google Scholar
  13. K. van der Putten, B. Braam, K. E. Jie, and C. A. J. M. Gaillard, “Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure,” Nature Clinical Practice Nephrology, vol. 4, no. 1, pp. 47–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Neven, T. M. De Schutter, G. J. Behets, A. Gupta, and P. C. D'Haese, “Iron and vascular calcification: is there a link?” Nephrology Dialysis Transplantation, vol. 26, no. 4, pp. 1137–1145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. K. Snell-Bergeon, M. J. Budoff, and J. E. Hokanson, “Vascular calcification in diabetes: mechanisms and implications,” Current Diabetes Reports, vol. 13, no. 3, pp. 391–402, 2013. View at Google Scholar
  16. S. Panizo, A. Cardus, M. Encinas et al., “RANKL increases vascular smooth muscle cell calcification through a rank-bmp4-dependent pathway,” Circulation Research, vol. 104, no. 9, pp. 1041–1048, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Bostrom, K. E. Watson, S. Horn, C. Wortham, I. M. Herman, and L. L. Demer, “Bone morphogenetic protein expression in human atherosclerotic lesions,” Journal of Clinical Investigation, vol. 91, no. 4, pp. 1800–1809, 1993. View at Google Scholar · View at Scopus
  18. M. Wu, C. Rementer, and C. M. Giachelli, “Vascular calcification: an update on mechanisms and challenges in treatment,” Calcified Tissue International, vol. 93, no. 4, pp. 365–373, 2013. View at Google Scholar
  19. P. Stenvinkel, O. Heimbürger, B. Lindholm, G. A. Kaysen, and J. Bergström, “Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome),” Nephrology Dialysis Transplantation, vol. 15, no. 7, pp. 953–960, 2000. View at Google Scholar · View at Scopus
  20. H. Zeki Tonbul, M. Demir, L. Altintepe et al., “Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients,” Renal Failure, vol. 28, no. 4, pp. 287–294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. C. Kim, H. W. Kim, S. W. Oh et al., “Low iPTH can predict vascular and coronary calcifications in patients undergoing peritoneal dialysis,” Nephron, vol. 117, no. 2, pp. c113–c119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. M. Chertow, S. K. Burke, and P. Raggi, “Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients,” Kidney International, vol. 62, no. 1, pp. 245–252, 2002. View at Publisher · View at Google Scholar · View at Scopus